Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
UNSPSC Code:
12352200
NACRES:
NA.54
Storage temp.:
2-8°C
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderform
powder
packaging
pkg of 27 g
manufacturer/tradename
Roche
storage temp.
2-8°C
General description
Blocking reagent is used for blocking of nonspecific binding sites in ELISA procedures.
Application
For research use only. Not for use in diagnostic procedures.
Blocking reagent has been used as a blocking reagent in:
Blocking reagent has been used as a blocking reagent in:
- ELISA
- Immunofluorescence
- In situ hybridization
Preparation Note
Storage conditions (working solution): Autoclaved stock solution can be stored for several days to one week either unopened at 15 to 25 °C or at 2 to 8 °C after opening. Alternatively, the stock solution can be stored in aliquots at -15 to -15 °C for up to 6 months.
Other Notes
For life science research only. Not for use in diagnostic procedures.
Classe de stockage
11 - Combustible Solids
wgk
WGK 1
flash_point_f
does not flash
flash_point_c
does not flash
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Contenu apparenté
Sara Mravinacova et al.
New biotechnology, 66, 46-52 (2021-10-11)
Highly accurate serological tests are key to assessing the prevalence of SARS-CoV-2 antibodies and the level of immunity in the population. This is important to predict the current and future status of the pandemic. With the recent emergence of new
David Drews et al.
BMC developmental biology, 9, 45-45 (2009-07-30)
The transcription factor Yin Yang 2 (YY2) shares a structural and functional highly homologue DNA-binding domain with the ubiquitously expressed YY1 protein, which has been implicated in regulating fundamental biological processes. However, the biological relevance of YY2 has not been
Anja K Wege et al.
mAbs, 6(4), 968-977 (2014-05-30)
Humanized tumor mice (HTM) were generated by the co-transplantation of human hematopoietic stem cells and human breast cancer cells overexpressing HER2 into neonatal NOD-scid IL2Rγ(null) (NSG) mice. These mice are characterized by the development of a human immune system in